These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21764463)

  • 1. Lymphocyte calcium influx kinetics in multiple sclerosis treated without or with interferon β.
    Toldi G; Folyovich A; Simon Z; Zsiga K; Kaposi A; Mészáros G; Tulassay T; Vásárhelyi B
    J Neuroimmunol; 2011 Aug; 237(1-2):80-6. PubMed ID: 21764463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of Kv1.3 and IKCa1 potassium channel inhibition on calcium influx of human peripheral T lymphocytes in rheumatoid arthritis.
    Toldi G; Bajnok A; Dobi D; Kaposi A; Kovács L; Vásárhelyi B; Balog A
    Immunobiology; 2013 Mar; 218(3):311-6. PubMed ID: 22705192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-lymphocyte calcium influx characteristics and their modulation by Kv1.3 and IKCa1 channel inhibitors in the neonate.
    Toldi G; Treszl A; Pongor V; Gyarmati B; Tulassay T; Vásárhelyi B
    Int Immunol; 2010 Sep; 22(9):769-74. PubMed ID: 20601376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte activation in type 1 diabetes mellitus: the increased significance of Kv1.3 potassium channels.
    Toldi G; Vásárhelyi B; Kaposi A; Mészáros G; Pánczél P; Hosszufalusi N; Tulassay T; Treszl A
    Immunol Lett; 2010 Sep; 133(1):35-41. PubMed ID: 20603149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different calcium influx characteristics upon Kv1.3 and IKCa1 potassium channel inhibition in T helper subsets.
    Orbán C; Bajnok A; Vásárhelyi B; Tulassay T; Toldi G
    Cytometry A; 2014 Jul; 85(7):636-41. PubMed ID: 24827427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis by flow cytometry of calcium influx kinetics in peripheral lymphocytes of patients with rheumatoid arthritis.
    Bajnok A; Kaposi A; Kovács L; Vásárhelyi B; Balog A; Toldi G
    Cytometry A; 2013 Mar; 83(3):287-93. PubMed ID: 23335202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-beta therapy reduces CD4+ and CD8+ T-cell reactivity in multiple sclerosis.
    Zafranskaya M; Oschmann P; Engel R; Weishaupt A; van Noort JM; Jomaa H; Eberl M
    Immunology; 2007 May; 121(1):29-39. PubMed ID: 17239199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon gamma and interleukin 4 producing T cells in peripheral blood of multiple sclerosis patients undergoing immunomodulatory treatment.
    Franciotta D; Zardini E; Bergamaschi R; Andreoni L; Cosi V
    J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):123-6. PubMed ID: 12486283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.
    Ochi H; Feng-Jun M; Osoegawa M; Minohara M; Murai H; Taniwaki T; Kira J
    J Neurol Sci; 2004 Jul; 222(1-2):65-73. PubMed ID: 15240198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting TH1 cells in humans.
    Rep MH; van Oosten BW; Roos MT; Adèr HJ; Polman CH; van Lier RA
    J Clin Invest; 1997 May; 99(9):2225-31. PubMed ID: 9151795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 1 and type 2 cytokine-producing CD4+ and CD8+ T cells in primary antiphospholipid syndrome.
    Karakantza M; Theodorou GL; Meimaris N; Mouzaki A; John E; Andonopoulos AP; Maniatis A
    Ann Hematol; 2004 Nov; 83(11):704-11. PubMed ID: 15300407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
    Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of aging on calcium influx and potassium channel characteristics of T lymphocytes.
    Kollár S; Berta L; Vásárhelyi ZE; Balog A; Vásárhelyi B; Rigó J; Toldi G
    Oncotarget; 2015 May; 6(15):13750-6. PubMed ID: 25948778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis.
    Krakauer M; Sorensen PS; Khademi M; Olsson T; Sellebjerg F
    Scand J Immunol; 2006 Aug; 64(2):155-63. PubMed ID: 16867161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymic output and peripheral T lymphocyte subsets in relapsing--remitting multiple sclerosis patients treated or not by IFN-beta.
    Puissant-Lubrano B; Viala F; Winterton P; Abbal M; Clanet M; Blancher A
    J Neuroimmunol; 2008 Jan; 193(1-2):188-94. PubMed ID: 18068811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
    Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
    J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term favorable response to interferon beta-1b is linked to cytokine deviation toward the Th2 and Tc2 sides in Japanese patients with multiple sclerosis.
    Mei FJ; Osoegawa M; Ochi H; Minohara M; Nan S; Murai H; Ishizu T; Taniwaki T; Kira J
    J Neurol Sci; 2006 Jul; 246(1-2):71-7. PubMed ID: 16581087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of chemokine receptors on Th1/Th2 CD4+ lymphocytes in patients with multiple sclerosis.
    Andalib A; Doulabi H; Najafi M; Tazhibi M; Rezaie A
    Iran J Immunol; 2011 Mar; 8(1):1-10. PubMed ID: 21427490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium Influx Kinetics and the Characteristics of Potassium Channels in Peripheral T Lymphocytes in Systemic Sclerosis.
    Toldi G; Legány N; Ocsovszki I; Balog A
    Pathobiology; 2020; 87(5):311-316. PubMed ID: 32911471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte calcium influx characteristics and their modulation by Kv1.3 and IKCa1 channel inhibitors in healthy pregnancy and preeclampsia.
    Toldi G; Stenczer B; Treszl A; Kollár S; Molvarec A; Tulassay T; Rigó J; Vásárhelyi B
    Am J Reprod Immunol; 2011 Feb; 65(2):154-63. PubMed ID: 20649894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.